Abstract
New advances in diagnostic technologies in nuclear medicine and radiopharmaceutical development, has led to the introduction of some potent copper-radiopharmaceuticals used in the diagnosis and/or therapy of human diseases. Copper radio nuclides provide a series of therapeutic/diagnostic tracers suitable for radiolabeling of small molecules, peptides, antibody fragments and monoclonal antibodies. The current status of copper radiopharmaceuticals for imaging, therapy and research studies of oncological processes is reviewed here with a look into the future directions as the conclusion.
Keywords: Copper radiosiotopes, radiopharmaceuticals, diagnosis, therapy, PET
Current Radiopharmaceuticals
Title: Production and Application of Copper Radiopharmaceuticals
Volume: 2 Issue: 2
Author(s): Amir Reza Jalilian, Pejman Rowshanfarzad and Mahsheed Sabet
Affiliation:
Keywords: Copper radiosiotopes, radiopharmaceuticals, diagnosis, therapy, PET
Abstract: New advances in diagnostic technologies in nuclear medicine and radiopharmaceutical development, has led to the introduction of some potent copper-radiopharmaceuticals used in the diagnosis and/or therapy of human diseases. Copper radio nuclides provide a series of therapeutic/diagnostic tracers suitable for radiolabeling of small molecules, peptides, antibody fragments and monoclonal antibodies. The current status of copper radiopharmaceuticals for imaging, therapy and research studies of oncological processes is reviewed here with a look into the future directions as the conclusion.
Export Options
About this article
Cite this article as:
Jalilian Reza Amir, Rowshanfarzad Pejman and Sabet Mahsheed, Production and Application of Copper Radiopharmaceuticals, Current Radiopharmaceuticals 2009; 2(2) . https://dx.doi.org/10.2174/1874471010902020092
DOI https://dx.doi.org/10.2174/1874471010902020092 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling
Current Drug Targets Short-Chain Fatty Acid Inhibitors of Histone Deacetylases: Promising Anticancer Therapeutics?
Current Cancer Drug Targets In Vivo Inhibition of the Estrogen Sulfatase Enzyme and Growth of DMBA-Induced Mammary Tumors by Melatonin
Current Cancer Drug Targets The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy
Current Pharmaceutical Design Muscarinic Acetylcholine Receptors: New Potential Therapeutic Targets in Antinociception and in Cancer Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Near-infrared Light Activatable Multimodal Gold Nanostructures Platform: An Emerging Paradigm for Cancer Therapy
Current Cancer Drug Targets Heparanase Patents: Dim Past and Bright Future
Recent Patents on Inflammation & Allergy Drug Discovery The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Exosome-like Nanoparticles: A New Type of Nanocarrier
Current Medicinal Chemistry Benefits and Challenges of Antivirulence Antimicrobials at the Dawn of the Post-Antibiotic Era
Drug Delivery Letters Selenium Compounds and Apoptotic Modulation: A New Perspective in Cancer Therapy
Mini-Reviews in Medicinal Chemistry Identification and Characterization of New Proteins in Podocyte Dysfunction of Membranous Nephropathy by Proteomic Analysis of Renal Biopsy
Current Pharmacogenomics and Personalized Medicine Functions of S100 Proteins
Current Molecular Medicine Recent Advances in Receptor-Targeted Fluorescent Probes for In Vivo Cancer Imaging
Current Medicinal Chemistry Targeting Proliferating Cell Nuclear Antigen (PCNA) as an Effective Strategy to Inhibit Tumor Cell Proliferation
Current Cancer Drug Targets Progress and Prospects: The Use of 3D Spheroid Model as a Relevant Way to Study and Optimize DNA Electrotransfer
Current Gene Therapy The Impact of L-Carnitine and Coenzyme Q10 as Protection Against Busulfan-Oxidative Stress in the Liver of Adult Rats
The Natural Products Journal Progress in Imaging Agents of Cell Apoptosis
Anti-Cancer Agents in Medicinal Chemistry Inflammatory and Non-Inflammatory Roles for Toll-Like Receptors in Gastrointestinal Cancer
Current Pharmaceutical Design <i>In Vivo</i> Anti-Tumor Effects of Flavokawain A in 4T1 Breast Cancer Cell-Challenged Mice
Anti-Cancer Agents in Medicinal Chemistry